A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
AstraZeneca
AstraZeneca
Neonc Technologies, Inc.
Azienda Ospedaliero-Universitaria di Parma
Eli Lilly and Company
University of Colorado, Denver
Maia Biotechnology
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
Maia Biotechnology
Mayo Clinic
Inhibrx Biosciences, Inc
University of Pittsburgh
Numab Therapeutics AG
University of Birmingham
Revolution Medicines, Inc.
Intensity Therapeutics, Inc.
Sarcoma Oncology Research Center, LLC
Carisma Therapeutics Inc
Advaxis, Inc.
Advaxis, Inc.
Pfizer
Sinocelltech Ltd.
H. Lee Moffitt Cancer Center and Research Institute
Revolution Medicines, Inc.
Seagen Inc.
Fate Therapeutics
Wuhan University
H. Lee Moffitt Cancer Center and Research Institute
Rain Oncology Inc
Amgen
M.D. Anderson Cancer Center
Revolution Medicines, Inc.
MacroGenics
Takeda
Celgene
Lumos Pharma
Ottawa Hospital Research Institute
M.D. Anderson Cancer Center
Tianjin Medical University Cancer Institute and Hospital
M.D. Anderson Cancer Center
Hoffmann-La Roche
Celgene
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Sanofi
Eli Lilly and Company
Memorial Sloan Kettering Cancer Center
Guangdong Association of Clinical Trials
Memorial Sloan Kettering Cancer Center
First People's Hospital of Hangzhou